Initial Public Offering (Details Narrative) - USD ($) |
6 Months Ended | |
|---|---|---|
Mar. 30, 2026 |
Apr. 30, 2026 |
|
| Subsidiary, Sale of Stock [Line Items] | ||
| Transaction costs | $ 1,866,553 | |
| Cash underwriting fee | 1,400,000 | |
| IPO [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Sale of units in initial public offering | 11,200,000 | |
| Share price per share | $ 10.00 | |
| Units description | Each Unit had a price of $10.00 and consists of one Public Share, and one Public Right to receive one fifth (1/5) of an ordinary share upon the consummation of an initial Business Combination. | |
| Other offering costs | $ 466,553 | |
| IPO [Member] | Underwriters [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Sale of units in initial public offering | 1,500,000 | |
| Over-Allotment Option [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Sale of units in initial public offering | 1,200,000 | 1,200,000 |
| Options exercised | 300,000 |
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|